Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00537212|
Recruitment Status : Completed
First Posted : October 1, 2007
Last Update Posted : February 2, 2012
|Condition or disease||Intervention/treatment||Phase|
|Psoriasis Weight Loss Diet||Other: The South Beach Diet Other: The Ornish Diet Other: Control Group||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Single-Center, Prospective, Single-Blinded, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy|
|Study Start Date :||June 2007|
|Primary Completion Date :||August 2008|
|Study Completion Date :||August 2008|
Active Comparator: 1
Subjects will receive phototherapy and dietary counselling consistent with "The South Beach diet."
Other: The South Beach Diet
Subjects will receive dietary counselling aimed at reducing simple carbohydrates and increasing weight loss. Subjects also receive a copy of "The South Beach Diet."
Active Comparator: 2
Subjects will receive phototherapy and dietary counselling consistent with "The Ornish Diet."
Other: The Ornish Diet
Subjects will receive dietary counselling aimed to reduce fat consumption and increase weight loss. Subjects also receive a copy of "The Ornish Diet" book.
No Intervention: 3
Subjects will receive phototherapy alone, without dietary counselling.
Other: Control Group
This group will receive phototherapy alone. They will not be counselled or give literature on a particular diet.
- PASI improvement [ Time Frame: 12 weeks ]
- which group's PASI did better [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00537212
|United States, New Jersey|
|East Windsor, New Jersey, United States, 08520|
|Principal Investigator:||Jerry Bagel, M.D.||Psoriasis Treatment Center of Central New Jersey|